Catalyst Reaction · NASDAQ: NRIX · Biotechnology
Nurix Therapeutics (NRIX): Sanofi's decision to discontinue development, a 38.2% drop and what followed
Nurix Therapeutics (NRIX) announced Sanofi's decision to discontinue development of STAT6 degrader SAR448272 at 4:01 PM ET on Tuesday, November 3, and the stock went from Tuesday’s $25.82 close to as low as $14.78. It finished the session −38.2% at $15.95 on 6.9 times its 20-day average volume. Here is how it traded, turn by turn, and how LiveChart’s stack read each one.
By IndicatorStack · · All times ET
The catalyst
What the company released or filed, to the minute it crossed. It’s in the timeline as a shaded row, linked to the source.
How it traded
The price around it, session by session: the gap, the range, the close, with the chart LiveChart draws from those bars.
How the stack read it
LiveChart’s read at each turn: the 5-minute trend (the stack bias), the higher timeframes (Compass), the flow (Undertow) and traps (Tripwire).
How the stack read it, checkpoint by checkpoint
The stack bias is LiveChart’s read of the 5-minute trend at that moment: a green dot is bullish, red bearish, grey no clear direction. Under it, what Compass read on the higher timeframes the trend is measured against.
- BeforeBearishTue close · $25.84Leaning down
- Into the openBearishWed 9:30 AM · $17.15Tailwind down
- 30 minutes inBearishWed 10:00 AM · $15.48Tailwind down
- At the closeNeutralWed 4:00 PM · $15.95Tailwind down
- Thursday’s closeBearishThu 4:00 PM · $14.81Tailwind down
- Friday’s closeBearishFri 4:00 PM · $15.29Tailwind down
- Monday’s closeNeutralMon 4:00 PM · $16.13Tailwind down
The timeline
Everything that happened, in order, on one ET clock: the company’s releases and SEC filings next to the price and the stack’s own turns.
- ReleaseSECShaded rows are the catalyst: the company’s own releases and filings
- PriceThe session’s open, high, low and close
- StackLiveChart’s 5-minute bias changed
- TriggerA hypothetical entry at the default settings
- TripwireA break of a level that failed to hold
Tuesday, November 3
- ReleaseSanofi's decision to discontinue development of STAT6 degrader SAR448272Press release, GlobeNewsWire
- SECCurrent report (Form 8-K) filedAccepted by the SEC at 4:02:18 PM ET
Wednesday, November 4
- PricePremarket high $19.01−26.4% from the prior close
- Stack5-minute stack bias turned bearishat $17.23
- TriggerTrigger marked a short at $17.15Hypothetical, default settings: reached $16.13 at 9:40 AM for +5.9% (target)
- PriceOpened at $17.16−33.5% from Tuesday’s $25.82 close
- TripwireTripwire flagged a trap at the lowsa push through support that failed to hold, at $15.01
- PriceSession low $14.78
- TripwireTripwire flagged a trap at the highsa push through resistance that failed to hold, at $15.32
- Stack5-minute stack bias turned bullishat $15.48
- Stack5-minute stack bias went neutralat $15.69, its inputs no longer agreeing
- PriceClosed at $15.95, −38.2% on the day19.6M shares, 6.9× its 20-day average
Thursday, November 5
- ReleaseTo Present new and updated data from ongoing Phase 1a/1b trial of bexobrutidegPress release, GlobeNewsWire
- Stack5-minute stack bias turned bearishat $15.91
- PriceOpened at $16.01+0.4% from Wednesday’s $15.95 close
- PriceSession high $16.59
- Stack5-minute stack bias turned bullishat $16.54
- Stack5-minute stack bias went neutralat $15.91, its inputs no longer agreeing
- Stack5-minute stack bias turned bearishat $15.97
- Stack5-minute stack bias went neutralat $16.15, its inputs no longer agreeing
- Stack5-minute stack bias turned bullishat $16.11
- Stack5-minute stack bias went neutralat $15.98, its inputs no longer agreeing
- Stack5-minute stack bias turned bearishat $15.98
- SECAmended ownership stake (Schedule 13G/A) filedAccepted by the SEC at 1:22:27 PM ET
- PriceSession low $14.80
- PriceClosed at $14.84, −7.0% on the day7.1M shares, 1.9× its 20-day average
Friday, November 6
- PriceOpened at $15.10+1.8% from Thursday’s $14.84 close
- PriceSession low $14.79
- Stack5-minute stack bias turned bullishat $15.32
- PriceSession high $15.52
- Stack5-minute stack bias went neutralat $15.23, its inputs no longer agreeing
- Stack5-minute stack bias turned bearishat $15.19
- PriceClosed at $15.30, +3.1% on the day3M shares, 0.7× its 20-day average
Monday, November 9
- Stack5-minute stack bias turned bullishat $15.31
- PriceOpened at $15.32+0.1% from Friday’s $15.30 close
- PriceSession low $15.27
- PriceSession high $16.63
- Stack5-minute stack bias went neutralat $16.13, its inputs no longer agreeing
- PriceClosed at $16.14, +5.5% on the day7.6M shares, 1.9× its 20-day average
Tuesday, November 3
Before the catalyst
Nurix Therapeutics closed Tuesday at $25.82. The 5-minute stack bias was bearish (weakening), since 12:45 PM: under VWAP 26.04 and a falling SMA, momentum down and trend strength with the sellers. Compass read “Leaning down” (15m ↘ 1h ↘ 2h ↘ 4h ↗ D ↗). Undertow: volume surge, buyers hitting the offer. Tripwire: Shorts: Clean, nothing major in the way. Its Next row read “Bounce, resistance to hold at 26.04 (VWAP)”.
Over the year before, it had traded between $11.67 and $28.23. The daily chart below shows where it was trading, and the bar the catalyst printed.
Bearishweakening · 5m stack bias · $25.84
- Compass
- Leaning down
- Undertow
- Volume surge
- Tripwire
- Shorts: Clean
- Next
- Bounce, resistance to hold at 26.04 (VWAP)
Wednesday, November 4
The release and a 38.2% drop
The release crossed at 4:01 PM ET on Tuesday. It opened at $17.16, −33.5%, and the regular session ranged from $14.78 to $17.28 before closing at $15.95. It did this on a day SPY rose 1.7% and XBI, the biotechnology ETF, rose 2.7%.
Into the open the stack read it as bearish (strong) with 5 of 5 higher timeframes down, and Undertow read “volume surge”. Thirty minutes in, the picture had changed: price was below VWAP at $16.20 and the Next row read “Stretched below the averages, bounce area near 15.95”. By the close the 5-minute bias was neutral, while Compass still read “Tailwind down”: the day’s trend on the 5-minute chart had turned while the higher timeframes it is measured against had not.
Bearishstrong · 5m stack bias · $17.15
- Compass
- Tailwind down
- Undertow
- Volume surge
- Tripwire
- Shorts: Avoid
- Next
- Trend down, fast EMA at 17.22, longs run against the bias
Bearishstrong · 5m stack bias · $15.48
- Compass
- Tailwind down
- Undertow
- Volume surge
- Tripwire
- Shorts: Clean
- Next
- Stretched below the averages, bounce area near 15.95
Neutral5m stack bias · $15.95
- Compass
- Tailwind down
- Undertow
- Volume surge
- Tripwire
- Longs: Caution
- Next
- Range 15.56 to 16.58, no edge in the middle
Thursday, November 5
The session after
It opened at $16.01 (+0.4%) and traded from $14.80 to $16.59, closing at $14.84, −7.0% on 7.1M shares, still 1.9 times its 20-day average. The 5-minute stack bias was bearish (strong), since 12:15 PM: under VWAP 15.72 and a falling SMA, momentum down, net selling and trend strength with the sellers. Compass read “Tailwind down” (15m ↓ 1h ↓ 2h ↓ 4h ↓ D ↓). Undertow: volume surge, sellers hitting the bid. Tripwire: Shorts: Clean, nothing major in the way.
Bearishstrong · 5m stack bias · $14.81
- Compass
- Tailwind down
- Undertow
- Volume surge
- Tripwire
- Shorts: Clean
- Next
- Stretched below the averages, bounce area near 15.02
Friday, November 6
The session after
It opened at $15.10 (+1.8%) and traded from $14.79 to $15.52, closing at $15.30, +3.1% on 3M shares, still 0.7 times its 20-day average. The 5-minute stack bias was bearish (weakening), since 2:15 PM: momentum down. Compass read “Tailwind down” (15m ↘ 1h ↘ 2h ↘ 4h ↓ D ↘). Undertow: volume surge, buyers hitting the offer. Tripwire: Shorts: Avoid, resistance looks thin, buying tape on it.
Bearishweakening · 5m stack bias · $15.29
- Compass
- Tailwind down
- Undertow
- Volume surge
- Tripwire
- Shorts: Avoid
- Next
- Reclaimed VWAP 15.23, sellers need a rejection
Monday, November 9
The session after
It opened at $15.32 (+0.1%) and traded from $15.27 to $16.63, closing at $16.14, +5.5% on 7.6M shares, still 1.9 times its 20-day average. The 5-minute stack bias was neutral, its inputs disagreeing. Compass read “Tailwind down” (15m ↗ 1h ↓ 2h ↓ 4h ↓ D ↘). Undertow: volume surge, buyers hitting the offer. Tripwire: Longs: Caution, against the daily and weekly cycle.
After hours it last traded at $16.14, with Undertow reading “buyers lead”.
Neutral5m stack bias · $16.13
- Compass
- Tailwind down
- Undertow
- Volume surge
- Tripwire
- Longs: Caution
- Next
- Range 16.05 to 16.32, no edge in the middle
Neutral5m stack bias · $16.14
- Compass
- Tailwind down
- Undertow
- Buyers lead
- Tripwire
- Longs: Avoid
- Next
- Range 16.05 to 16.32, no edge in the middle
Shares, float and insiders
The supply picture
What the company has outstanding, and what its insiders and its share history show, from its SEC filings.
- Shares outstanding
- 109Mas reported to the SEC
- Float
- 104M95% of shares outstanding
- Last insider sale
- November 4, 20263K shares at $15.38
Releases and filings
Sources
The company’s own releases and its filings with the SEC, newest first, each with the time it crossed.
- SECAmended ownership stake (Schedule 13G/A)Thu Nov 5, 1:22 PM ET · SEC EDGAR
- ReleaseTo Present new and updated data from ongoing Phase 1a/1b trial of bexobrutidegThu Nov 5, 7:00 AM ET · GlobeNewsWire
- SECCurrent report (Form 8-K)Tue Nov 3, 4:02 PM ET · SEC EDGAR
- ReleaseSanofi's decision to discontinue development of STAT6 degrader SAR448272Tue Nov 3, 4:01 PM ET · GlobeNewsWire
In short
Questions
Why did NRIX stock go down on November 4?
Nurix Therapeutics (NRIX) announced Sanofi's decision to discontinue development of STAT6 degrader SAR448272 at 4:01 PM ET on Tuesday, November 3, and the stock went from Tuesday’s $25.82 close to as low as $14.78. It finished the session −38.2% at $15.95 on 6.9 times its 20-day average volume. The reaction describes the sequence and infers no cause.
What did Nurix Therapeutics announce on November 3, 2026?
Nurix Therapeutics (NRIX) announced Sanofi's decision to discontinue development of STAT6 degrader SAR448272 at 4:01 PM ET on Tuesday, November 3.
How did NRIX stock trade on November 4?
NRIX opened at $17.16, −33.5% from the prior close of $25.82, traded between $14.78 and $17.28 in the regular session and closed at $15.95, −38.2%, on 19.6M shares.
How did LiveChart’s stack read NRIX at the close on November 4?
At the 4:00 PM ET close the 5-minute stack bias on NRIX was neutral, Compass read “Tailwind down” and Undertow read “volume surge”. Each turn of the read is on this page’s timeline.
What does LiveChart’s stack read on NRIX now?
The read on this page is fixed at each moment it describes. LiveChart reads NRIX on every bar as it trades: open it on LiveChart for the current stack bias, levels and every layer.
Every catalyst on NRIX
NRIX’s catalyst history
This is NRIX’s first Catalyst Reaction. Each time it moves on a release or a filing again, the reads line up here side by side, so how it reacts to its own news builds into a history.
| Session | The catalyst | The day | Next session | Stack bias at the close |
|---|---|---|---|---|
| Nov 4, 2026This reaction | Sanofi's decision to discontinue development of STAT6 degrader SAR448272Company news · 4:01 PM ET | −38.2% | −7.0% | Neutral |
Also on Wednesday, November 4
More Catalyst Reactions from that session
- Nov 49:01 AM ETLYEL+43.3%Lyell Immunopharma (LYEL): Phase 1 data, a 43.3% session and what followedTrial data6.9× avg volume
- Nov 48:45 AM ETPARA−88.3%Parabolic Technologies, Inc. Class A (PARA): a public offering, an 88.3% drop and a $0.0000 offeringOffering8.8× avg volume
- Nov 47:30 AM ETCNSY−31.4%Cerenome (CNSY): Secures National In-Network agreement with Aetna, a 31.4% drop and what followedCompany news1.6× avg volume
- Nov 45:36 PM ETHPAI+37.2%Helport AI (HPAI): advances Transition to autonomous AI Labor, a 37.2% session and what followedCompany news90.9× avg volume
- Nov 45:00 PM ETCMTG+66.7%Claros Mortgage Trust (CMTG): quarterly results, a 66.7% session and what followedEarnings33.1× avg volume
- Nov 44:10 PM ETTREE+32.8%LendingTree (TREE): quarterly results, a 32.8% session and what followedEarnings5.1× avg volume
Every Reaction From Nov 4More Company News ReactionsNRIX Catalyst HistoryNRIX on LiveChartTechnical Setups RadarAll Catalyst ReactionsIntraday Movers
Further reading: Gaps: continuation and exhaustionLow-float riskWhat VWAP tells youTrading around halts
General market information from the company’s releases, its SEC filings, the session’s prices and LiveChart’s reads. Prices are indicative. It describes what happened and when, infers no cause, takes no view on what comes next and is not a recommendation to buy or sell any security. Trigger trades are hypothetical. Read the Risk Disclosure.